These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immunologic monitoring with Orthoclone OKT3 therapy. Schroeder TJ; First MR; Hurtubise PE; Marmer DJ; Martin DM; Mansour ME; Melvin DB J Heart Transplant; 1989; 8(5):371-80. PubMed ID: 2529358 [TBL] [Abstract][Full Text] [Related]
5. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling. Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138 [TBL] [Abstract][Full Text] [Related]
6. Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection: analysis beyond 4 years. Sharma LC; Muirhead N; Lazarovits AI Transplant Proc; 1997; 29(1-2):323-4. PubMed ID: 9123021 [No Abstract] [Full Text] [Related]
7. Expansion of CD4+CD7- T helper cells with a TH0-TH2 function in kidney transplant recipients. Barrou B; Legac E; Blanc C; Bitker MO; Luciani J; Chatelain C; Debré P; Autran B Transplant Proc; 1995 Apr; 27(2):1676-7. PubMed ID: 7536977 [No Abstract] [Full Text] [Related]
8. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes. Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954 [TBL] [Abstract][Full Text] [Related]
9. Failure of anti-CD20 monoclonal antibody therapy to prevent antibody-mediated rejection in three crossmatch-positive renal transplant recipients. Matignon M; Tagnaouti M; Audard V; Dahan K; Lang P; Grimbert P Transplant Proc; 2007 Oct; 39(8):2565-7. PubMed ID: 17954175 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade. Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623 [TBL] [Abstract][Full Text] [Related]
11. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice. Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869 [TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory properties of FK734, a humanized anti-CD28 monoclonal antibody with agonistic and antagonistic activities. Shiao SL; McNiff JM; Masunaga T; Tamura K; Kubo K; Pober JS Transplantation; 2007 Feb; 83(3):304-13. PubMed ID: 17297405 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of skin xenograft rejection by depleting T-cell receptor alpha beta-bearing cells without T-cell receptor gamma delta-bearing cells or natural killer cells by monoclonal antibody. Nishimura Y; Eto M; Maeda T; Hiromatsu K; Kobayashi N; Nomoto K; Kong YY; Nomoto K Immunology; 1994 Oct; 83(2):196-204. PubMed ID: 7835935 [TBL] [Abstract][Full Text] [Related]
14. Xenotransplantation and ABO incompatible transplantation: the similarities they share. Galili U Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361 [TBL] [Abstract][Full Text] [Related]
15. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse. Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473 [TBL] [Abstract][Full Text] [Related]
16. Production and characterization of the extracellular domain of human CD7 antigen: further evidence that CD7 has a role in T cell signaling. Leta E; Roy AK; Hou Z; Jung LK Cell Immunol; 1995 Oct; 165(1):101-9. PubMed ID: 7545547 [TBL] [Abstract][Full Text] [Related]
17. In vivo effects of IgA and IgG2a anti-CD3 isotype switch variants. Parlevliet KJ; ten Berge IJ; Yong SL; Surachno J; Wilmink JM; Schellekens PT J Clin Invest; 1994 Jun; 93(6):2519-25. PubMed ID: 8200988 [TBL] [Abstract][Full Text] [Related]
18. Novel humanized anti-CD3 antibodies induce a predominantly immunoregulatory profile in human peripheral blood mononuclear cells. Silva HM; Vieira PM; Costa PL; Pimentel BM; Moro AM; Kalil J; Maranhão AQ; Coelho V; Brigido MM Immunol Lett; 2009 Aug; 125(2):129-36. PubMed ID: 19573559 [TBL] [Abstract][Full Text] [Related]
19. An overview of the use of the monoclonal antibody OKT3 in renal transplantation. Norman DJ Transplant Proc; 1988 Dec; 20(6):1248-52. PubMed ID: 2974204 [TBL] [Abstract][Full Text] [Related]
20. [The immunobiology of transplant rejection and its pharmacological modification]. Köhler H; Zanker B; Strom TB Dtsch Med Wochenschr; 1991 Feb; 116(7):264-9. PubMed ID: 1825196 [No Abstract] [Full Text] [Related] [Next] [New Search]